- Home
- XTNT vs OPTN Comparison
XTNT vs OPTN Comparison
Compare XTNT & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- OPTN
- Stock Information
- Founded
- XTNT N/A
- OPTN 2010
- Country
- XTNT United States
- OPTN United States
- Employees
- XTNT N/A
- OPTN N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- OPTN Health Care
- Exchange
- XTNT Nasdaq
- OPTN Nasdaq
- Market Cap
- XTNT 60.9M
- OPTN 55.4M
- IPO Year
- XTNT N/A
- OPTN 2017
- Fundamental
- Price
- XTNT $0.47
- OPTN $9.16
- Analyst Decision
- XTNT Strong Buy
- OPTN Hold
- Analyst Count
- XTNT 1
- OPTN 3
- Target Price
- XTNT $3.00
- OPTN $9.00
- AVG Volume (30 Days)
- XTNT 33.4K
- OPTN 175.2K
- Earning Date
- XTNT 03-06-2025
- OPTN 05-13-2025
- Dividend Yield
- XTNT N/A
- OPTN N/A
- EPS Growth
- XTNT N/A
- OPTN N/A
- EPS
- XTNT N/A
- OPTN N/A
- Revenue
- XTNT $117,267,000.00
- OPTN $78,226,000.00
- Revenue This Year
- XTNT $15.56
- OPTN $38.89
- Revenue Next Year
- XTNT $22.39
- OPTN $18.64
- P/E Ratio
- XTNT N/A
- OPTN N/A
- Revenue Growth
- XTNT 28.44
- OPTN 10.20
- 52 Week Low
- XTNT $0.33
- OPTN $4.82
- 52 Week High
- XTNT $1.14
- OPTN $21.45
- Technical
- Relative Strength Index (RSI)
- XTNT 45.30
- OPTN 81.08
- Support Level
- XTNT $0.45
- OPTN $9.12
- Resistance Level
- XTNT $0.54
- OPTN $9.35
- Average True Range (ATR)
- XTNT 0.04
- OPTN 0.24
- MACD
- XTNT 0.00
- OPTN 0.18
- Stochastic Oscillator
- XTNT 36.55
- OPTN 89.70
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.